David Dobrowski

David Dobrowski has a strong background in clinical development, regulatory affairs, and product safety. David is currently the Vice President of Clinical Development & Regulatory Affairs at ABK Biomedical Inc. In their previous role as a Consultant at Direct Development Consulting LLC, they provided comprehensive consulting to drug and medical device firms in various areas such as clinical development, regulatory affairs, and business development. David also served as the Vice President, Head of Research and Development at Merz North America, where they were responsible for the strategic management of R&D. Prior to that, they held leadership positions in regulatory affairs at Salix Pharmaceuticals, Schwarz Biosciences, Wyeth Vaccines, and Novartis Ophthalmics. David began their career as a Microbiologist at AAI Development Services before transitioning into roles related to corporate compliance at Catalytica.

David Dobrowski attended the University of North Carolina Wilmington from 1988 to 1992, where they earned a Bachelor of Science degree in Marine Biology.